Because of the soft-tissue envelope and the dimensional complexity of the muscular contraction of the mentalis muscle, the projection and shape of the chin is not determined by only the bony projection. In a subset of patients with a seemingly underprojected chin, a hyperactive, high-riding mentalis muscle contributes to a blunted chin contour.
T he contour of the chin is defined by the bony architecture and the overlying soft-tissue elements, including the skin, fibrofatty tissue pad, and mentalis muscle. Because of the soft-tissue envelope and the dimensional complexity of the muscular contraction of the mentalis muscle, the projection and shape of the chin is not determined by only the bony projection. The position of the most projecting point anteriorly is also determined by the overlying soft tissue and can thus be modified by addressing the soft tissue in addition to the bony projection. In a subset of patients with a seemingly underprojected chin, a hyperactive, high-riding mentalis muscle contributes to a blunted chin contour. We hypothesized that the chin aesthetic in this type of patient could be improved by injection of onabotulinumtoxinA (Botox Cosmetic [botulinum toxin A]; Allergan, Inc) into the mentalis muscle, thus relaxing the muscle and allowing it to descend. This relaxation could theoretically improve the overall chin aesthetic by reducing bunching and tension, consequently altering the projection of the chin and its contour.
Methods
We evaluated a case series of patients before and after intervention in a private facial plastic surgery practice from August 25, 2006, to November 10, 2012 . Because this case series was conducted in a private institution and not an academic center, no institutional review board oversight occurred. The study design, implementation, data collection, and analysis were performed in accordance with the World Medical Association Declaration of Helsinki. 1 The data collection and analysis had no bearing on patient intervention or outcomes. All patients provided written informed consent for the use of their photographs for data and research purposes before the procedure. Inclusion criteria consisted of presentation with an undesirable appearance of the chin, specifically an underprojected bony chin and a high-riding hyperactive mentalis muscle. Most patients also had dimpling, although this was not an inclusion criteria. Patients were excluded if, within the previous 6 months, they had any facial procedures, such as a rhinoplasty or face-lift, that may affect the facial measurements because of postprocedure swelling. Patients were not excluded if they had prior chin interventions, including chin implantation, filler injection, onabotulinumtoxinA injection, or chin implant removal, if interventions were not performed during the exclusion window of 6 months. Candidates were advised of their surgical and nonsurgical treatment options, which included injection of onabotulinumtoxinA, filler injection, and chin implantation. Patients who chose to receive onabotulinumtoxinA injection were asked if they would be willing to participate in the study. Those who agreed to participate provided appropriate consent prior to injection.
Preinjection photographs were taken. Patients were injected with 12 to 15 U of onabotulinumtoxinA into the mentalis muscle in 2-to 3-U aliquots. Patients were seen in follow-up and examined approximately 2 weeks after the injection (mean, 14.5 days; range, 6-28 days). Postinjection photographs were taken, and the patients were surveyed on their degree of satisfaction with the procedure and whether they experienced any functional complications.
Cephalometric analysis was performed on the position of the pogonion relative to fixed facial points before and after injection. Photographic measurements were taken with Adobe Photoshop software (Adobe Systems, Inc), using the ruler tool to calculate pixel distances. The horizontal position (x) of the pogonion was measured with respect to a line drawn through the nasion perpendicular to the Frankfort horizontal plane, and the vertical position (y) was measured with respect to the Frankfort horizontal plane (Figure 1) . The x and y distances were measured for preinjection and postinjection photographs. To account for variations in the size of the face among photographs, a ratio was used between the x and y values and the nasal length from the nasion to the subnasale.
Data were analyzed from November 13, 2012, to April 9, 2013. Statistical analysis was then performed on the adjusted ratio values using a paired 2-tailed t test with P = .05 for statistical significance.
Results
Eleven patients (3 men and 8 women; mean [SD] age, 46.3 [16.4] years) were included in the study. Two patients had chin implants prior to injection but were still dissatisfied with their chin appearance. One patient had a previous chin implant that was removed because he was not happy with the appearance after several adjustments.
All 11 patients treated displayed improvement in their overall chin aesthetic, with a change in chin projection as measured by the position of the pogonion. The vertical position of the pogonion was more inferior after injection in 10 of 
Key Points
Question Does onabotulinumtoxinA favorably alter the chin aesthetic in patients with a hyperactive mentalis muscle and an underprojected bony chin?
Findings In this case series, 11 patients with a hyperactive mentalis muscle were injected with 12 to 15 U of onabotulinumtoxinA, and a photographic analysis was performed. Patients demonstrated a significant inferior displacement in the vertical position of the pogonion, and all patients reported an improvement in their overall chin aesthetic.
Meaning OnabotulinumtoxinA can be used to improve the chin aesthetic in carefully selected patients and is a useful nonsurgical tool to consider when addressing the chin aesthetically. the position of the pogonion was more posterior after injection. Patients also demonstrated improved appearance of the chin contour on profile, with an overall more rounded rather than blunted contour (Figures 1, 2, 3 , 4, and 5). Figures 3 and 4 show patients who had chin implants placed prior to injection and experienced further improvement in chin aesthetic after injection with botulinum toxin. Dimpling and bunching (Figures 2, 3 , and 4) were also significantly reduced on frontal view. All patients reported satisfaction from the treatment, and no adverse effects were noted after injection. No patients reported functional complications, such as oral incompetence, speech impairment, mouth asymmetry, or weakness of the lower lip. All patients mentioned a decrease in the perception of tension in their chin and an improvement in their overall chin appearance after mentalis injection. Both effects faded after approximately 4 to 5 months in all patients. The patient in Figure 5 had decreased projection after injection but an overall favorable improvement in chin contour. This patient elected to have an implant placed after injection to achieve additional projection. The remaining 10 patients in the study stated that they would be interested in intermittent injections to maintain their appearance. Seven of the 11 patients (64%) returned for additional treatments. In 3 patients, distance and cost were limiting factors. Some patients did not live nearby, and the treatment was provided without charge for the study purposes but not for additional injections. 
Research Original Investigation Modification of Chin Projection and Aesthetics With Botox Injection Discussion
The aesthetic appearance of the chin is multifactorial and related to the bony and soft tissue anatomy. Traditionally, chin projection and contour have been modified by altering the bony projection with surgical augmentation and reduction along with adjunctive use of fillers. A subset of patients who desire chin augmentation or modification display an underprojected bony chin in combination with a hyperactive, highriding mentalis muscle. In patients with a hyperactive mentalis muscle, the pogonion appears closer to the lip, and the chin assumes a more blunted appearance at its inferior aspect when viewed in profile. Although chin implantation in this clinical scenario can improve the projection of the bony chin, a hyperactive mentalis muscle overlying an implant may still result in a suboptimal contour that may benefit from injection with onabotulinumtoxinA. OnabotulinumtoxinA has been used safely and effectively in the chin for multiple indications that have been well described in the literature. Aesthetically, it has been used to improve the surface topography of the chin subunit by reducing bunching and dimpling of the skin.
2-4 OnabotulinumtoxinA is also used frequently in combination with dermal fillers for rejuvenation of the chin and lower face. 5, 6 Additional applications include the use of onabotulinumtoxinA in the mentalis muscle to treat neurologic conditions such as lower hemifacial spasm and hereditary essential chin myoclonus. 7, 8 In this case series, we describe modification of chin projection and contour on profile as an additional aesthetic application for the use of onabotulinumtoxinA. In patients with a high-riding mentalis muscle, photographic cephalometric analysis showed a statistically significant inferior displacement in vertical position of the pogonion after neuromodula- tor injection. Although the horizontal position of the pogonion changed in all patients, the difference was not significant, and an approximately equal number of patients experienced increased vs decreased projection. In patients with decreased anterior projection after injection, the decrease was usually related to the relaxation of the high-riding mentalis muscle and the resulting volumetric shift of soft tissue inferiorly and posteriorly. The overall chin contour and curvature were still improved despite the decrease in projection, as demonstrated in Figure 5 . Two patients had undergone previous chin implantation but had further improvement in contour after onabotulinumtoxinA injection, suggesting that neuromodulator injection may be a useful adjunct even in patients undergoing chin implantation. No adverse events were experienced. All patients were pleased with their postinjection appearance, although 1 patient sought further improvement with chin implantation after injection.
The development of mentalis dysfunction has been described after augmentation mentoplasty with an implant, resulting in dimpling and bunching of the mentalis above the level of the implant. 9, 10 Chin ptosis may also occur because of a disruption of the insertion of the mentalis muscle during surgical exposure for the implant, particularly during an intraoral approach. Mentalis dysfunction can also result in a palpable soft tissue mass accentuated by mentalis contraction; this finding can occur after chin augmentation or sliding genioplasty and may be the result of mentalis hyperfunction. 11, 12 Depending on the cause of the dysfunction, surgical approaches and onabotulinumtoxinA injection have both been used to successfully address this condition. 10, 11 OnabotulinumtoxinA has been used to treat surface irregularities such as dimpling and bunching, whereas surgical reinsertion and suspension of the mentalis muscle to the anterior mandible is often required to correct ptosis. 11, 12 It is our opinion that the most attractive aesthetics of the chin occur when the most projecting point is also the lowest point on the mandible. If the pogonion is positioned above the mandibular border, it creates the appearance of a weak chin regardless of the true projection. The shape of the labiomental angle is altered on profile view after onabotulinumtoxinA injection because of the inferior displacement of the chin pad, and we find this to be a favorable aesthetic change.
We hypothesize that the hyperactive high-riding appearance of the mentalis muscle may be because of a higher resting tone of the mentalis, a possible disinsertion of the mentalis from its bony insertion along the lower mandibular border, or a combination of both. The hyperactive and high-riding mentalis may also be a form of compensation for an underprojected bony chin. The more highly positioned mentalis may help with the tone of the lower lip, although the patients in this series did not report any complaints or problems associated with the relaxation of the muscle after injection. Injection with onabotulinumtoxinA into the mentalis had the expected result of relaxing the muscle, allowing the muscle and overlying chin pad to descend over the bony chin, resulting in the improved rounded contour seen on profile view. This technique can be used either alone to enhance the appearance of the chin or in combination with filler injection or an alloplastic implant. A subset of patients may achieve satisfactory chin aesthetics with this technique alone and potentially avoid surgery altogether. Injection of onabotulinumtoxinA for a hyperactive, high-riding mentalis muscle provides the surgeon or the clinician an additional tool to address the chin aesthetic unit.
Limitations
The primary study limitation was the sample size. A larger sample would have allowed a comparison between demographic groups and an analysis of results in patients with prior or current chin implant. Another study limitation was variation in patient photographs that precluded analysis of both profile views.
Conclusions
OnabotulinumtoxinA is effective at improving chin aesthetics by altering the position of the pogonion and improving chin contour on profile. Patients demonstrated a significant inferior displacement in the vertical position of the pogonion. All patients experienced a change in chin projection, although the difference was not statistically significant. In addition, the overall volume of the chin was distributed more inferiorly with a more rounded contour on profile. This report is, to our knowledge, the first analysis of the influence of onabotulinumtoxinA injection to the mentalis muscle on the position of the pogonion. This nonsurgical mentoplasty may be used as an independent procedure or as an adjunct to optimize traditional chin augmentation in carefully selected patients. 
